Top Marijuana Stocks to Watch Next Week: Your Guide to Potential High-Growth Investments

Marijuana Market Movers: Stocks to Watch in the Coming Week

As the cannabis industry in the U.S. continues to expand, marijuana stocks are gaining attention from investors. The U.S. cannabis market was valued at $13.2 billion in 2022 and is projected to reach $41.5 billion by 2027. This rapid growth is driven by increasing legalization and acceptance of cannabis for medical and recreational use. Recent headlines highlight ongoing discussions in Congress about federal legalization, which could further boost the industry. Watching marijuana penny stocks now allows investors to capitalize on future market gains.

When investing in marijuana penny stocks, technical analysis and proper risk management are crucial. Technical analysis involves studying price charts and indicators to make informed decisions. This method helps identify entry and exit points to maximize returns. However, risk management is essential due to the volatile nature of penny stocks. Diversifying your portfolio and setting stop-loss orders can mitigate potential losses. By combining these strategies, investors can navigate the dynamic cannabis market with greater confidence and potentially high rewards.

[Read More] 3 Marijuana Stocks for Your 2024 Watch List This Month

Next Week’s Top Marijuana Stocks: Key Players to Add to Your Watchlist

  1. Acreage Holdings, Inc. (OTC: ACRHF)
  2. Glass House Brands Inc. (OTC: GLASF)
  3. Cansortium Inc. (OTC: CNTMF)

Acreage Holdings, Inc.

Acreage Holdings, Inc. (ACRHF) is a prominent player in the U.S. cannabis industry. The company operates a vast network of retail locations, offering a wide range of cannabis products. They currently have over 30 stores, with a strong presence in states like New York, New Jersey, and Massachusetts. Acreage Holdings focuses on providing high-quality cannabis to both medical and recreational users. Their extensive retail footprint and commitment to quality have positioned them as a leader in the market.

In addition to its retail operations, Acreage Holdings is involved in cultivation, processing, and distribution. This vertical integration allows them to control the entire supply chain, ensuring product consistency and reliability. They also collaborate with industry leaders to enhance their product offerings. With ongoing legislative changes and increasing acceptance of cannabis, Acreage Holdings is well-positioned for future growth. Investors are closely monitoring ACRHF as they continue to expand and innovate within the industry.

Fourth Quarter and Full Year 2023 Financial Highlights

Acreage Holdings, Inc. reported its financial results for the fourth quarter and full year ending December 31, 2023. The company achieved positive Adjusted EBITDA for the 12th consecutive quarter, highlighting its consistent financial performance. In Q4 2023, Acreage generated a consolidated revenue of $52.8 million, with a gross margin of 32%. Excluding non-cash inventory adjustments, the adjusted gross margin was 33%. However, the net loss for Q4 2023 was $35.7 million, impacted by market price compression and inflation. Despite these challenges, Acreage reduced its operating expenses by 72% year-over-year, with a nearly 50% decrease in general and administrative expenses.

Throughout 2023, Acreage focused on expanding its flagship brands, The Botanist and Superflux. The company launched Superflux in New Jersey and deepened its operations in the state by expanding the Egg Harbor facility. Additionally, Acreage debuted The Botanist THC-infused gummies in New York, broadening its product offerings. Recent developments include entering New York’s adult-use wholesale market and relocating a dispensary to Vernon, Connecticut. With the approval of Canopy shareholders for reorganization, Acreage is poised for further growth. CEO Dennis Curran emphasized the company’s strategic initiatives and the strong positioning ahead of its acquisition by Canopy USA.

[Read More] Top Marijuana Penny Stocks to Add to Your Watchlist This Week

Glass House Brands Inc

Glass House Brands Inc. (GLASF) is a leading cannabis and hemp company in the United States. Its focus is on sustainable cultivation, manufacturing, and retailing of high-quality cannabis products. The company operates multiple stores, primarily in California, where it has the most significant presence. Glass House Brands is committed to delivering premium cannabis experiences to its customers.


Glass House Brands’ vertically integrated model allows them to control every aspect of their product journey. They cultivate cannabis in state-of-the-art greenhouse facilities, ensuring top-tier quality. Additionally, the company has expanded its retail footprint to cater to the growing demand for cannabis. This includes a variety of product lines, such as flower, pre-rolls, and edibles. Glass House Brands continues to innovate and adapt as the market evolves, maintaining a strong position in the industry. Their commitment to sustainability and quality makes them stand out in the cannabis sector.

First Quarter 2024 Financial Highlights

Glass House Brands Inc. reported its first-quarter financial results for 2024, showcasing robust performance. The company achieved a revenue of $30.1 million, marking a 9% increase year-over-year. Biomass production also saw a significant boost, reaching 61,334 pounds, up 28% from the previous year. The cost per pound of production decreased to $182, reflecting a 7% reduction. The company’s cash balance stood at $24 million by the end of the quarter. Greenhouse 5 is now operating at full capacity and is expected to contribute significantly to Q2 revenues, projected to reach between $52 million and $54 million.

The first quarter saw various operational achievements for Glass House Brands. Despite a sequential revenue decline due to seasonal factors, the company maintained strong gross profit margins at 42%. Retail revenue grew to $9.9 million, and wholesale CPG revenues increased to $4.3 million. The company also saw improved production efficiency and product quality at its Greenhouse 5 facility. CEO Kyle Kazan highlighted the successful launch of the Allswell Eighth, which was priced competitively and drove increased sales and foot traffic across their stores. Looking ahead, the company anticipates setting new revenue records in the second quarter and maintaining its strategic focus on expanding production and sales.

[Read More] Top MSO Marijuana Stocks to Watch This Memorial Day Weekend

Cansortium Inc.

Cansortium Inc. (CNTMF) is a vertically integrated cannabis company that cultivates, processes and retails high-quality cannabis products. The company operates under the Fluent brand, offering a range of medical cannabis products. Cansortium has a strong presence in Florida, operating over 30 dispensaries. Additionally, they have expanded into Texas, Pennsylvania, and Michigan, solidifying their footprint in key medical cannabis markets.


Cansortium’s commitment to quality and patient care sets them apart in the cannabis industry. They employ state-of-the-art cultivation techniques to ensure the highest standards of product quality. Their dispensaries provide a personalized patient experience, offering a variety of cannabis forms such as flower, edibles, tinctures, and concentrates. As the medical cannabis market grows, Cansortium continues to innovate and expand its offerings. This positions them well for future growth and increased market share in the competitive cannabis sector.

Fourth Quarter and Full Year 2023 Financial Highlights

Cansortium Inc. reported record revenue and positive cash flow for the fourth quarter and full year ending December 31, 2023. Q4 revenue rose by 9% year-over-year to $25.5 million, marking their ninth consecutive quarter of positive cash flow from operations. Florida revenue increased by 11%, reaching $21.6 million. Adjusted gross profit was $12.6 million, representing 49.4% of revenue. However, adjusted EBITDA decreased to $6.9 million due to higher SG&A expenses from additional stores. The company had $10.5 million in cash and cash equivalents and $61.2 million in total debt at year-end.

For 2023, Cansortium’s revenue grew by 11% to $97.3 million, with Florida’s revenue increasing by 11% to $81.2 million. Adjusted gross profit was $49.5 million, and adjusted EBITDA rose to $27.2 million. Operational highlights included opening four dispensaries in Florida in 2023 and two new locations in early 2024, bringing the total to 35. CEO Robert Beasley emphasized the company’s strategic investments and operational improvements, particularly in cultivation and product quality. Plans include expanding their footprint in Florida and Pennsylvania and opening a delivery center in Houston, Texas, by early 2025.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Top Marijuana Stocks To Watch As Markets Pull Back In July? 2 For Your List This Week

Could These Be Winning Marijuana Stocks For Your Long Term Portfolio?